Endogenous Candida endophthalmitis in drug misusers injecting intravenous buprenorphine;Endophtalmie endogène à Candida secondaire à l'utilisation de la buprénorphine par voie intraveineuse

Journal Francais d'Ophtalmologie

Volumn 31, Issue 2, 2008, Pages 180-183

  Hirsbein, D ^a   Attal, P ^a   Gueudry, J ^a   Guet, I ^a   Brasseur, G ^a   Vasseneix, C ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Buprenorphine; Candida; Endophthalmitis; Vitrectomy

Indexed keywords

EID: 42949116833     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(08)70351-6     Document Type: Article

References (14)

1. Vidal-Trecan G, Varescon I, Nabet N, Boissonnas A. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug Alcohol Depend, 2003;69:175-81.
2. Umbricht A, Huestis MA, Cone EJ, Preston KL. Effects of high-dose intravenous buprenorphine in experience opioid abusers. J Clin Psychopharmacol, 2004;24:479-87.
3. Moller M, Althaus C, Sundmacher R. Bilateral candida endophtalmitis in 2 i.v. drug-dependent patients with oral L-methadone substitution. Klin Monatsbl Augenheilkd, 1997l;211:53-6.
4. Feroni I, Paraponaris A, Aubisson S, Bouhnik A, Masut A, Ronfle E, et al . [Prescription of high dose buprenorphine by general practitioners]. Rev Épidemiol Santé Publique, 2004;52:511-22.
5. Cassoux N, Bodaghi B, Lehoang P, Edel Y. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex). Br J Ophthalmol, 2002;86:940-1.
6. Schelenz S, Gransden WR. Candidemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses, 2003;46:390-6.
7. Hidalgo JA, Alangaden GJ, Eliott D, Akins RA, Puklin J, Abrams G, Vazquez JA. Fungal endophthalmitis diagnosis by detection of Candida albicans DNA in intraocular fluid by use of a species-specific polymerase chain reaction assay. J Infect Dis, 2000;181:1198-201.
8. Mora P, Bovey EH, Guex-Crosier Y. Mycotic endophthalmitis: management and treatment (9 year study). Klin Monatsbl Augenheilkd, 2002;219:221-5.
9. Neppert B, Guthoff R, HeidemannHT. Endogenous candida endophthalmitis in a drug dependent patient: intravenous therapy with liposome encapsulated amphotericin B. Klin Monatsbl Augenheilkd, 1992;201:122-4.
10. Malecaze F, Linas MD, Gazagne C, Pagot V, Mathis A, Seguela JP. [Diffusion intraoculaire des antifongiques et les conséquences thérapeutiques dans les mycoses oculaires]. Journal de mycologie médicale, 1992;2:73-6.
11. Urbak SF, Degn T. fluconazole in the treatment of candida albicans endophthalmitis. Acta Ophthalmol (Copenh), 1992;70:528-9.
12. Cazorla C, Grenier de Cardenal D, Schuhmacher H, Thomas L, Wack A, May T, et al. [Infectious complications and misuse of high-dose buprenorphine]. Presse Med, 2005;34:719-24.
13. Kauffman CA. Fungal infections. Proc Am Thorac Soc, 2006;3:35-40.
14. Craig AA, John RD, Penny A. Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species. MJA, 2005;182:427.